Indacaterol/ Glycopyrronium in Symptomatic Patients with COPD (GOLD 2 and GOLD 3) Versus Salmeterol/ Fluticasone. Indus Journal of Bioscience Research, [S. l.], v. 3, n. 4, p. 614–617, 2025. DOI: 10.70749/ijbr.v3i4.859. Disponível em: https://ijbr.com.pk/IJBR/article/view/859. Acesso em: 14 aug. 2025.